GARY J WHITMAN

Concepts (542)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mammography
92
2024
1045
10.290
Why?
Ultrasonography, Mammary
38
2024
386
8.560
Why?
Breast Neoplasms
137
2024
16196
6.450
Why?
Breast Diseases
14
2021
206
4.210
Why?
Breast
46
2024
1379
3.500
Why?
Radiographic Image Enhancement
18
2014
410
2.410
Why?
Magnetic Resonance Imaging
47
2024
7927
2.380
Why?
Mass Screening
19
2024
1553
2.250
Why?
Image-Guided Biopsy
7
2020
337
1.810
Why?
Diagnostic Imaging
7
2024
1178
1.770
Why?
Biopsy, Needle
22
2019
1401
1.600
Why?
Surgical Instruments
4
2023
139
1.590
Why?
Cicatrix
2
2024
186
1.410
Why?
Triple Negative Breast Neoplasms
11
2024
1372
1.390
Why?
Image Interpretation, Computer-Assisted
7
2018
593
1.370
Why?
Lymph Nodes
11
2023
3067
1.340
Why?
Mastectomy, Segmental
9
2021
1047
1.330
Why?
Artifacts
7
2023
537
1.310
Why?
Female
172
2024
148622
1.220
Why?
Carcinoma, Lobular
9
2024
617
1.200
Why?
Lymphatic Metastasis
13
2023
4967
1.190
Why?
Calcinosis
13
2011
432
1.180
Why?
Carcinoma, Ductal, Breast
13
2018
1233
1.180
Why?
Multimodal Imaging
5
2020
553
1.170
Why?
Humans
238
2024
271060
1.100
Why?
Carcinoma, Intraductal, Noninfiltrating
10
2020
693
1.040
Why?
Neoadjuvant Therapy
22
2024
5206
0.960
Why?
Biopsy
13
2023
3544
0.950
Why?
Early Detection of Cancer
7
2024
1331
0.940
Why?
Radiographic Image Interpretation, Computer-Assisted
10
2013
379
0.940
Why?
Archives
1
2024
5
0.930
Why?
Breast Carcinoma In Situ
1
2024
17
0.920
Why?
Vascular Neoplasms
2
2023
113
0.840
Why?
Radiology Information Systems
4
2015
118
0.810
Why?
Hemangioma
1
2023
160
0.770
Why?
Contrast Media
8
2020
1510
0.760
Why?
Preoperative Care
6
2022
1547
0.750
Why?
Mastitis
1
2020
12
0.740
Why?
Granulomatous Mastitis
1
2020
9
0.740
Why?
Genes, BRCA1
3
2020
388
0.730
Why?
Angiomatosis
2
2021
27
0.720
Why?
Breast Neoplasms, Male
3
2018
231
0.720
Why?
Retrospective Studies
46
2024
39720
0.720
Why?
Radiology
9
2024
428
0.710
Why?
Hemangiosarcoma
1
2023
237
0.710
Why?
Carcinoma, Papillary
3
2018
581
0.700
Why?
Middle Aged
95
2024
90103
0.680
Why?
Genes, BRCA2
2
2020
310
0.670
Why?
Neoplasm Staging
20
2024
13979
0.660
Why?
Axilla
7
2023
924
0.650
Why?
Diagnosis, Differential
16
2020
4886
0.640
Why?
Sensitivity and Specificity
21
2020
5187
0.640
Why?
Phyllodes Tumor
2
2018
65
0.640
Why?
Vulnerable Populations
1
2020
185
0.630
Why?
Hyperplasia
6
2021
581
0.620
Why?
Machine Learning
1
2021
356
0.610
Why?
Adult
85
2024
81619
0.610
Why?
Image Enhancement
4
2017
555
0.600
Why?
Gadolinium DTPA
1
2018
173
0.590
Why?
Ultrasonography, Interventional
2
2018
417
0.560
Why?
Stereotaxic Techniques
3
2017
183
0.560
Why?
Breast Density
1
2016
20
0.550
Why?
Ultrasonography
19
2023
1938
0.550
Why?
Aged
64
2024
73250
0.530
Why?
Foreign-Body Migration
1
2017
121
0.530
Why?
Molecular Imaging
1
2017
187
0.500
Why?
Positron Emission Tomography Computed Tomography
1
2020
878
0.480
Why?
Imaging, Three-Dimensional
5
2014
916
0.470
Why?
Mobile Health Units
1
2013
35
0.450
Why?
Congresses as Topic
1
2015
296
0.450
Why?
Radiography
23
2024
1988
0.430
Why?
Radiographic Magnification
3
2009
15
0.430
Why?
Cone-Beam Computed Tomography
3
2009
210
0.420
Why?
Tomography, X-Ray Computed
32
2020
7786
0.410
Why?
Formative Feedback
2
2023
33
0.410
Why?
Algorithms
10
2011
3907
0.410
Why?
X-Ray Film
2
2009
31
0.410
Why?
Subtraction Technique
2
2002
145
0.400
Why?
Workload
2
2013
199
0.390
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2013
166
0.390
Why?
Guideline Adherence
2
2017
647
0.390
Why?
Magnetic Resonance Imaging, Interventional
1
2012
106
0.390
Why?
Osteosarcoma
1
2019
948
0.390
Why?
ROC Curve
14
2024
1237
0.380
Why?
Attitude of Health Personnel
3
2015
918
0.380
Why?
Observer Variation
10
2014
720
0.380
Why?
Biopsy, Large-Core Needle
3
2020
139
0.370
Why?
Patient Selection
3
2018
2041
0.370
Why?
Papilloma, Intraductal
2
2020
17
0.360
Why?
Elasticity Imaging Techniques
1
2013
186
0.360
Why?
Efficiency, Organizational
2
2009
94
0.350
Why?
Monitoring, Intraoperative
1
2011
264
0.350
Why?
Ultrasonography, Doppler, Color
2
2007
108
0.350
Why?
Liver Neoplasms
5
2020
4795
0.350
Why?
Fibroma
2
2006
87
0.330
Why?
Radiologists
3
2022
178
0.320
Why?
Fat Necrosis
1
2009
59
0.320
Why?
Task Performance and Analysis
1
2009
137
0.310
Why?
Precancerous Conditions
3
2011
1066
0.310
Why?
Pregnancy Complications, Neoplastic
2
2007
235
0.300
Why?
Sentinel Lymph Node Biopsy
4
2021
1449
0.290
Why?
Artificial Intelligence
2
2024
438
0.290
Why?
Lymphoma, B-Cell
3
2011
935
0.280
Why?
Monte Carlo Method
3
2009
697
0.280
Why?
Reproducibility of Results
15
2024
6187
0.280
Why?
Phantoms, Imaging
9
2023
1330
0.280
Why?
Chondroblastoma
1
2006
15
0.270
Why?
Follow-Up Studies
11
2021
15249
0.270
Why?
Ilium
1
2006
54
0.260
Why?
Inflammatory Breast Neoplasms
2
2023
528
0.250
Why?
Mammary Glands, Human
2
2008
185
0.250
Why?
Clinical Competence
5
2021
1323
0.250
Why?
Sacrum
1
2006
139
0.250
Why?
Fibromatosis, Aggressive
2
2004
110
0.250
Why?
Aortic Rupture
2
1996
116
0.250
Why?
Lipoma
2
2004
94
0.250
Why?
Spirituality
1
2006
129
0.240
Why?
Prospective Studies
11
2024
13375
0.240
Why?
Liposarcoma
2
2000
247
0.240
Why?
Radius
1
2024
44
0.240
Why?
Mesentery
1
2004
74
0.230
Why?
Scotland
1
2024
43
0.230
Why?
Mastectomy
5
2022
1547
0.230
Why?
Diagnosis, Computer-Assisted
4
2013
169
0.220
Why?
Positron-Emission Tomography
5
2020
2198
0.220
Why?
Aged, 80 and over
20
2024
30966
0.220
Why?
Adenocarcinoma
3
2020
7936
0.220
Why?
Practice Guidelines as Topic
4
2017
2428
0.210
Why?
Diffusion Magnetic Resonance Imaging
3
2022
341
0.210
Why?
Personnel Selection
1
2024
85
0.210
Why?
Practice Patterns, Physicians'
5
2017
1322
0.210
Why?
Communication
2
2021
856
0.210
Why?
Intestinal Neoplasms
1
2004
201
0.210
Why?
Aortic Aneurysm, Abdominal
2
1996
348
0.200
Why?
Radiography, Thoracic
3
2002
473
0.200
Why?
Radiography, Dual-Energy Scanned Projection
1
2002
57
0.200
Why?
Fluorodeoxyglucose F18
3
2020
1259
0.200
Why?
Diffusion Tensor Imaging
1
2024
295
0.190
Why?
Adenoma
2
2004
741
0.190
Why?
Skin Neoplasms
1
2018
4838
0.190
Why?
Radiation Dosage
6
2014
1043
0.190
Why?
Phthalazines
2
2022
263
0.190
Why?
Esthetics
1
2021
116
0.190
Why?
Mentoring
1
2022
98
0.180
Why?
Chi-Square Distribution
2
2015
1323
0.180
Why?
United States
10
2024
16011
0.180
Why?
Pyelonephritis
2
1995
48
0.180
Why?
Leiomyoma
1
2001
161
0.180
Why?
Lung Diseases
4
1999
753
0.170
Why?
Antineoplastic Combined Chemotherapy Protocols
12
2023
16603
0.170
Why?
Learning
1
2023
432
0.170
Why?
Fellowships and Scholarships
1
2024
407
0.170
Why?
Mediastinal Neoplasms
2
2000
429
0.170
Why?
Nipple Discharge
1
2019
8
0.170
Why?
Whole Body Imaging
1
2020
113
0.170
Why?
Emphysema
2
1995
88
0.170
Why?
Feasibility Studies
6
2017
2347
0.160
Why?
Margins of Excision
1
2021
314
0.160
Why?
Oncolytic Virotherapy
1
2021
235
0.160
Why?
Advisory Committees
1
2020
210
0.160
Why?
Bone Neoplasms
2
2015
2667
0.160
Why?
Male
46
2020
128513
0.160
Why?
Hamartoma
1
1999
87
0.160
Why?
Chemotherapy, Adjuvant
9
2023
3972
0.160
Why?
Prognosis
15
2022
22464
0.150
Why?
Biological Products
1
2021
316
0.150
Why?
Response Evaluation Criteria in Solid Tumors
1
2018
165
0.150
Why?
Data Display
3
2013
52
0.150
Why?
Area Under Curve
3
2013
724
0.150
Why?
Peritoneal Neoplasms
1
2004
851
0.140
Why?
Treatment Outcome
14
2024
33850
0.140
Why?
Vacuum
3
2012
42
0.140
Why?
Connecticut
1
2016
37
0.140
Why?
Periodicals as Topic
1
2021
323
0.140
Why?
Uterine Neoplasms
1
2001
580
0.140
Why?
Minimally Invasive Surgical Procedures
1
1999
508
0.130
Why?
Decision Making
2
2016
1242
0.130
Why?
Paclitaxel
4
2020
2099
0.130
Why?
Antineoplastic Agents
2
2018
14682
0.130
Why?
Tumor Burden
2
2021
2034
0.130
Why?
Kidney
5
1996
2266
0.130
Why?
Fluorouracil
4
2020
1987
0.130
Why?
Surveys and Questionnaires
7
2024
5908
0.130
Why?
Retroperitoneal Fibrosis
1
1995
7
0.130
Why?
Coronary Artery Bypass
1
1999
568
0.130
Why?
Lymph Node Excision
4
2022
2044
0.130
Why?
Coronary Disease
1
1999
776
0.120
Why?
Neoplasm Invasiveness
4
2018
4069
0.120
Why?
Quality Assurance, Health Care
1
1999
612
0.120
Why?
Sentinel Lymph Node
1
2017
229
0.120
Why?
Age Distribution
2
2015
728
0.120
Why?
Incidental Findings
1
2016
282
0.120
Why?
Nephroma, Mesoblastic
1
1994
15
0.120
Why?
Image Processing, Computer-Assisted
2
2015
1708
0.120
Why?
Cost-Benefit Analysis
2
2013
966
0.110
Why?
Urinary Bladder Diseases
1
1994
54
0.110
Why?
Neoplasms, Multiple Primary
1
2017
559
0.110
Why?
Health Care Surveys
1
2015
423
0.110
Why?
Genetic Therapy
1
2021
1732
0.110
Why?
Retroperitoneal Neoplasms
2
1994
299
0.110
Why?
Guidelines as Topic
1
2015
371
0.110
Why?
Combined Modality Therapy
8
2021
9045
0.110
Why?
Physical Examination
1
2015
303
0.110
Why?
Cancer Care Facilities
1
2018
908
0.110
Why?
Lymphoma, Non-Hodgkin
2
1996
1068
0.110
Why?
Appointments and Schedules
1
2013
98
0.110
Why?
Texas
2
2018
6414
0.110
Why?
Neoplasm Recurrence, Local
7
2022
10351
0.110
Why?
Trastuzumab
1
2015
736
0.100
Why?
Databases, Factual
2
2018
2286
0.100
Why?
Cyclophosphamide
4
2020
3231
0.100
Why?
Computer Simulation
3
2009
1522
0.100
Why?
Mammaplasty
2
2015
715
0.100
Why?
Risk Factors
3
2024
17829
0.100
Why?
Forecasting
2
2013
707
0.100
Why?
Survival Rate
6
2018
12518
0.100
Why?
X-Ray Intensifying Screens
3
2006
35
0.100
Why?
Scattering, Radiation
2
2009
334
0.100
Why?
Radiopharmaceuticals
3
2013
1338
0.100
Why?
Receptor, ErbB-2
3
2023
2648
0.100
Why?
Carcinoma in Situ
3
2010
495
0.100
Why?
Feedback
2
2023
227
0.100
Why?
Premedication
1
1991
133
0.090
Why?
Kidney Neoplasms
3
1997
3145
0.090
Why?
Time Factors
7
2010
13112
0.090
Why?
Endometriosis
1
1994
235
0.090
Why?
Tamoxifen
1
1995
907
0.090
Why?
Pregnancy
4
2015
8096
0.090
Why?
False Negative Reactions
3
2017
294
0.090
Why?
Doxorubicin
4
2007
3138
0.090
Why?
Early Diagnosis
1
2011
315
0.090
Why?
Pilot Projects
3
2022
2852
0.090
Why?
Antineoplastic Agents, Hormonal
1
2015
853
0.090
Why?
Internship and Residency
1
2021
1432
0.090
Why?
Prostheses and Implants
2
2007
294
0.090
Why?
Spondylitis, Ankylosing
1
1989
29
0.090
Why?
Erythropoietin
1
1991
218
0.090
Why?
Receptors, Progesterone
2
2018
1646
0.090
Why?
Pattern Recognition, Automated
1
2010
125
0.080
Why?
Multiple Sclerosis
2
1990
376
0.080
Why?
Pandemics
3
2024
1597
0.080
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
880
0.080
Why?
Aortic Aneurysm
1
1991
219
0.080
Why?
Escherichia coli Infections
2
1996
272
0.080
Why?
Lung
7
2002
3271
0.080
Why?
Program Evaluation
2
2022
613
0.080
Why?
Radiography, Interventional
3
1999
312
0.080
Why?
Software
3
2010
1360
0.080
Why?
Receptors, Estrogen
2
2018
2264
0.080
Why?
Methotrexate
1
2011
1027
0.080
Why?
X-Rays
4
2009
153
0.070
Why?
Professional Competence
1
2009
135
0.070
Why?
User-Computer Interface
1
2009
304
0.070
Why?
Interferon-alpha
1
1992
961
0.070
Why?
Linear Models
1
2010
1092
0.070
Why?
Biopsy, Fine-Needle
1
2010
698
0.070
Why?
Tomography, Spiral Computed
1
2007
128
0.070
Why?
Radionuclide Imaging
1
2008
658
0.070
Why?
Immunohistochemistry
1
2018
7815
0.070
Why?
Lymphocytes, Tumor-Infiltrating
2
2022
1011
0.070
Why?
Cohort Studies
4
2015
9438
0.070
Why?
Scrotum
2
2004
60
0.070
Why?
Genes, p53
1
2011
1133
0.070
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2022
514
0.070
Why?
Rituximab
1
2011
1589
0.070
Why?
Medical Staff, Hospital
1
2006
123
0.070
Why?
Mutation
2
2020
15861
0.060
Why?
Dilatation, Pathologic
1
2005
98
0.060
Why?
Germ-Line Mutation
2
2022
1069
0.060
Why?
Young Adult
4
2021
22062
0.060
Why?
Genomics
1
2016
2818
0.060
Why?
Cytarabine
1
2011
2014
0.060
Why?
Antimetabolites, Antineoplastic
1
2011
1346
0.060
Why?
Anemia
1
1991
730
0.060
Why?
Genital Diseases, Male
1
2004
30
0.060
Why?
Histiocytosis, Sinus
1
2005
87
0.060
Why?
Myoma
1
2004
7
0.060
Why?
Epidermal Cyst
1
2004
47
0.060
Why?
Leukemic Infiltration
1
2004
73
0.060
Why?
Risk Assessment
3
2016
6832
0.060
Why?
Terminology as Topic
1
2006
419
0.060
Why?
Anisotropy
1
2024
186
0.060
Why?
Urography
2
1994
57
0.060
Why?
Contrast Sensitivity
2
2013
67
0.050
Why?
Education, Distance
1
2024
100
0.050
Why?
Drainage
1
1995
448
0.050
Why?
Necrosis
2
2020
604
0.050
Why?
Asbestosis
1
2002
8
0.050
Why?
Ergonomics
1
2022
27
0.050
Why?
Administration, Oral
2
2019
1618
0.050
Why?
Lymphangioma, Cystic
1
2001
23
0.050
Why?
Esthesioneuroblastoma, Olfactory
1
2003
115
0.050
Why?
Pleural Diseases
1
2002
58
0.050
Why?
Radiotherapy Planning, Computer-Assisted
2
2009
2452
0.050
Why?
Adolescent
3
2018
32553
0.050
Why?
Breast Implants
2
2015
376
0.050
Why?
Herpesvirus 1, Human
1
2021
115
0.050
Why?
Phenotype
3
2018
6464
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2004
439
0.050
Why?
Staining and Labeling
1
2022
465
0.050
Why?
Faculty, Medical
1
2024
308
0.050
Why?
Postoperative Complications
2
2015
5683
0.050
Why?
Intestine, Small
1
2004
526
0.050
Why?
Epirubicin
1
2020
159
0.050
Why?
Ketones
1
2020
58
0.050
Why?
Furans
1
2020
103
0.050
Why?
Nose Neoplasms
1
2003
237
0.040
Why?
Disease-Free Survival
3
2022
10250
0.040
Why?
Randomized Controlled Trials as Topic
2
2006
2673
0.040
Why?
Lymphocyte Count
1
2021
485
0.040
Why?
Mentors
1
2022
203
0.040
Why?
Hepatic Artery
1
2001
256
0.040
Why?
Calibration
2
2012
346
0.040
Why?
Thymoma
1
2003
253
0.040
Why?
Pneumonia
2
2004
798
0.040
Why?
Fluorescent Antibody Technique
1
2022
1153
0.040
Why?
Practice Management
1
1999
9
0.040
Why?
Epididymis
2
1997
73
0.040
Why?
Predictive Value of Tests
3
2016
4982
0.040
Why?
False Positive Reactions
2
2012
373
0.040
Why?
Biomarkers, Tumor
3
2017
10701
0.040
Why?
Antineoplastic Agents, Phytogenic
1
2004
896
0.040
Why?
Medical Oncology
1
2008
1462
0.040
Why?
Carcinoma, Renal Cell
1
1992
2415
0.040
Why?
Computer Communication Networks
1
1999
50
0.040
Why?
Technology, Radiologic
1
1999
78
0.040
Why?
Immobilization
1
1999
91
0.040
Why?
Anthracyclines
1
2021
339
0.040
Why?
Computer Systems
1
1999
117
0.040
Why?
Accreditation
1
2019
136
0.040
Why?
Health Care Rationing
1
1999
79
0.040
Why?
Thymus Neoplasms
1
2003
420
0.040
Why?
T-Lymphocyte Subsets
1
2021
595
0.040
Why?
Fluoroscopy
1
1999
223
0.040
Why?
Models, Biological
2
2008
3226
0.040
Why?
Workplace
1
1999
92
0.040
Why?
Efficiency
2
2008
93
0.040
Why?
Radiation Injuries
2
2003
1472
0.040
Why?
Parathyroid Neoplasms
1
1999
187
0.040
Why?
Neoplasm, Residual
4
2007
1740
0.040
Why?
Technetium
1
2017
80
0.040
Why?
Cauda Equina
1
1997
13
0.040
Why?
Taxoids
1
2021
1008
0.040
Why?
Mastectomy, Simple
1
2017
59
0.040
Why?
BRCA2 Protein
1
2019
370
0.040
Why?
Rosaniline Dyes
1
2017
109
0.040
Why?
Adenoma, Villous
1
1996
10
0.040
Why?
Immunophenotyping
1
2021
1730
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1996
8
0.030
Why?
Lymphoid Tissue
1
1997
102
0.030
Why?
Internet
1
2021
697
0.030
Why?
Fournier Gangrene
1
1996
4
0.030
Why?
Remission Induction
2
2015
3646
0.030
Why?
Peroneal Nerve
1
1996
5
0.030
Why?
Peripheral Nervous System Neoplasms
1
1997
72
0.030
Why?
Research Design
1
2024
1573
0.030
Why?
Fallopian Tube Neoplasms
1
1997
155
0.030
Why?
Preoperative Period
1
2017
349
0.030
Why?
Cholangitis
1
1996
51
0.030
Why?
Arteriovenous Malformations
1
1996
67
0.030
Why?
BRCA1 Protein
1
2019
516
0.030
Why?
Fasciitis, Necrotizing
1
1996
33
0.030
Why?
Lung Neoplasms
2
2015
11776
0.030
Why?
Pyelonephritis, Xanthogranulomatous
1
1995
1
0.030
Why?
Aspergillus fumigatus
1
1996
138
0.030
Why?
Adenoma, Liver Cell
1
1995
16
0.030
Why?
Canada
1
2017
429
0.030
Why?
Age Factors
4
1999
5487
0.030
Why?
Adenocarcinoma, Mucinous
1
1999
441
0.030
Why?
Hepatitis
1
1996
94
0.030
Why?
Programmed Cell Death 1 Receptor
1
2022
1089
0.030
Why?
Orbital Diseases
1
1996
121
0.030
Why?
Lung Diseases, Fungal
1
1996
133
0.030
Why?
Epididymitis
1
1995
2
0.030
Why?
B7-H1 Antigen
1
2022
1070
0.030
Why?
Thoracic Diseases
1
1995
30
0.030
Why?
Curriculum
1
2021
914
0.030
Why?
Esophageal Neoplasms
1
1989
3236
0.030
Why?
Mucormycosis
1
1996
118
0.030
Why?
Intraoperative Period
2
2007
259
0.030
Why?
Rhabdomyosarcoma, Embryonal
1
1996
76
0.030
Why?
Captopril
1
1994
37
0.030
Why?
Pneumonia, Pneumocystis
1
1995
75
0.030
Why?
Opportunistic Infections
1
1996
237
0.030
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
1994
18
0.030
Why?
Aspergillosis
1
1996
249
0.030
Why?
Tacrolimus
1
1996
351
0.030
Why?
Oropharynx
1
1994
80
0.030
Why?
Pulmonary Veins
1
1996
180
0.030
Why?
Medication Adherence
1
2019
517
0.030
Why?
Cysts
1
1996
208
0.030
Why?
Duodenal Diseases
1
1994
47
0.030
Why?
Eosinophilic Granuloma
1
1993
15
0.030
Why?
Vasculitis
1
1994
77
0.030
Why?
Sarcoidosis
1
1995
114
0.030
Why?
AIDS-Related Opportunistic Infections
1
1995
190
0.030
Why?
Diaphragm
1
1995
187
0.030
Why?
Neurilemmoma
1
1994
134
0.030
Why?
Cystoscopy
1
1994
92
0.030
Why?
Equipment Failure Analysis
2
2006
327
0.030
Why?
Abscess
1
1995
191
0.030
Why?
Kidney Diseases, Cystic
1
1993
66
0.030
Why?
Testicular Neoplasms
1
1997
554
0.030
Why?
Liquid Crystals
1
2012
3
0.030
Why?
Silicone Elastomers
1
1993
54
0.030
Why?
Colitis
1
1996
344
0.030
Why?
Models, Statistical
2
2009
1150
0.030
Why?
Solitary Pulmonary Nodule
1
1994
125
0.030
Why?
Lymphoproliferative Disorders
1
1995
383
0.030
Why?
Trachea
1
1994
290
0.030
Why?
Neoplasm Grading
1
2017
1820
0.030
Why?
Pulmonary Artery
1
1996
520
0.030
Why?
Amyloidosis
1
1994
186
0.030
Why?
Echo-Planar Imaging
1
1993
74
0.030
Why?
Hypertrophy
1
1992
160
0.030
Why?
Floxuridine
1
1992
41
0.030
Why?
Length of Stay
1
1999
2009
0.030
Why?
Pheochromocytoma
1
1995
312
0.030
Why?
Gene Expression Profiling
1
2004
5165
0.030
Why?
Graft Rejection
1
1996
866
0.020
Why?
Injections, Subcutaneous
1
1992
345
0.020
Why?
Signal-To-Noise Ratio
1
2011
126
0.020
Why?
Tumor Microenvironment
1
2022
2992
0.020
Why?
Reference Standards
1
2012
368
0.020
Why?
Thoracic Neoplasms
1
1994
347
0.020
Why?
Lung Transplantation
1
1995
389
0.020
Why?
Neuroblastoma
1
1997
701
0.020
Why?
Religion and Medicine
1
1991
46
0.020
Why?
Confidence Intervals
1
2012
754
0.020
Why?
Leucovorin
1
1992
344
0.020
Why?
Syringomyelia
1
1990
20
0.020
Why?
Kidney Transplantation
1
1996
789
0.020
Why?
HLA-B27 Antigen
1
1989
8
0.020
Why?
Biomarkers
1
2021
5107
0.020
Why?
Intubation, Intratracheal
1
1994
454
0.020
Why?
Paraffin
1
2009
13
0.020
Why?
Hysterectomy
1
1994
645
0.020
Why?
Cystectomy
1
1994
632
0.020
Why?
Immunosuppressive Agents
1
1996
1444
0.020
Why?
Analysis of Variance
1
2013
2318
0.020
Why?
Brain
1
2003
4251
0.020
Why?
Infusions, Intravenous
1
1992
1438
0.020
Why?
Surgical Flaps
1
2015
881
0.020
Why?
Medicare
1
2014
933
0.020
Why?
Calcification, Physiologic
1
2008
55
0.020
Why?
Muscle, Skeletal
1
1996
1313
0.020
Why?
Colonic Neoplasms
1
1996
1437
0.020
Why?
Radiotherapy
1
2015
1858
0.020
Why?
Clavicle
1
2007
66
0.020
Why?
Immunotherapy
1
2021
3534
0.020
Why?
Physicians
1
1996
871
0.020
Why?
Gene Expression
1
2016
3679
0.020
Why?
Decision Support Systems, Clinical
1
2011
268
0.020
Why?
Quality of Life
1
2022
4740
0.020
Why?
Liver Transplantation
1
1996
1184
0.020
Why?
Recurrence
3
2004
4884
0.020
Why?
Neoplasm Metastasis
2
2001
5326
0.020
Why?
Lymphoma, Large B-Cell, Diffuse
1
1997
1735
0.020
Why?
Aorta, Thoracic
1
1991
532
0.020
Why?
Equipment Design
1
2009
1207
0.020
Why?
Glioma
1
1997
1969
0.020
Why?
Dose-Response Relationship, Drug
1
2013
5106
0.020
Why?
Recombinant Proteins
1
1991
3073
0.020
Why?
Calcium Carbonate
1
2005
28
0.020
Why?
Child, Preschool
2
1999
16930
0.020
Why?
Punctures
1
1995
105
0.020
Why?
Bronchi
2
1997
329
0.020
Why?
Specimen Handling
1
2006
311
0.020
Why?
HIV Infections
1
1997
2157
0.010
Why?
Treatment Failure
1
2007
1432
0.010
Why?
Pancreatic Neoplasms
1
2001
5237
0.010
Why?
Oxides
1
2004
212
0.010
Why?
Arsenicals
1
2004
204
0.010
Why?
Aminoglycosides
1
2004
235
0.010
Why?
Women's Health
1
2004
203
0.010
Why?
Colonoscopy
2
1996
519
0.010
Why?
Tretinoin
1
2004
621
0.010
Why?
Nasal Cavity
1
2003
147
0.010
Why?
Radiotherapy Dosage
1
2009
4003
0.010
Why?
Carcinoma
1
1992
2627
0.010
Why?
Research
1
2003
427
0.010
Why?
Body Mass Index
1
2008
2237
0.010
Why?
Video Recording
1
2002
274
0.010
Why?
Prevalence
1
2008
3417
0.010
Why?
Dermatologic Surgical Procedures
1
2000
106
0.010
Why?
Neoplasms
1
2006
15861
0.010
Why?
Case-Control Studies
2
2001
6034
0.010
Why?
Radiotherapy, Adjuvant
1
2004
2266
0.010
Why?
Drug Administration Schedule
1
2004
3539
0.010
Why?
Prostatic Neoplasms
1
1996
5992
0.010
Why?
Cross-Sectional Studies
1
2008
4507
0.010
Why?
Pancreas
1
2001
744
0.010
Why?
Genetic Predisposition to Disease
1
2011
5438
0.010
Why?
Testicular Diseases
1
1997
22
0.010
Why?
Ileocecal Valve
1
1996
3
0.010
Why?
Pancreatectomy
1
2001
696
0.010
Why?
Ileal Diseases
1
1996
27
0.010
Why?
Cholangiography
1
1996
35
0.010
Why?
Bronchography
1
1996
24
0.010
Why?
Cholelithiasis
1
1996
49
0.010
Why?
Intussusception
1
1996
52
0.010
Why?
Palpation
1
1996
51
0.010
Why?
Sarcoidosis, Pulmonary
1
1995
20
0.010
Why?
Sternum
1
1996
96
0.010
Why?
HIV Antibodies
1
1995
95
0.010
Why?
Lymphatic Diseases
1
1995
130
0.010
Why?
Muscular Diseases
1
1995
163
0.010
Why?
Bile Ducts, Intrahepatic
1
1996
331
0.010
Why?
Sheep
1
1994
276
0.010
Why?
Postpartum Period
1
1995
262
0.010
Why?
Duodenum
1
1994
170
0.010
Why?
Prednisone
1
1996
1039
0.010
Why?
Thorax
1
1994
230
0.010
Why?
Hospitals, General
1
1992
32
0.010
Why?
Fatal Outcome
1
1995
835
0.010
Why?
Actuarial Analysis
1
1992
170
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2004
3397
0.010
Why?
Acquired Immunodeficiency Syndrome
1
1995
370
0.010
Why?
Massachusetts
1
1992
144
0.010
Why?
Graft Survival
1
1996
1093
0.010
Why?
Colon
1
1996
689
0.010
Why?
Peripheral Nervous System Diseases
1
1996
408
0.010
Why?
Immunocompromised Host
1
1996
722
0.010
Why?
Antibodies, Monoclonal
1
2004
4519
0.010
Why?
Ultrasonography, Prenatal
1
1997
912
0.010
Why?
Respiration, Artificial
1
1994
583
0.010
Why?
Gastric Mucosa
1
1994
659
0.010
Why?
Cross Infection
1
1994
548
0.010
Why?
Transplantation, Homologous
1
1996
3033
0.010
Why?
Delivery of Health Care
1
1996
872
0.010
Why?
Logistic Models
1
1996
3431
0.010
Why?
Adipose Tissue
1
1993
734
0.000
Why?
Spinal Cord
1
1990
726
0.000
Why?
Incidence
1
1996
5842
0.000
Why?
Liver
1
1995
3124
0.000
Why?
Hypertension
1
1994
1614
0.000
Why?
Smoking
1
1993
2427
0.000
Why?
Registries
1
1992
2238
0.000
Why?
Child
2
1996
30372
0.000
Why?
Infant, Newborn
1
1997
8580
0.000
Why?
Survival Analysis
1
1992
9305
0.000
Why?
Animals
1
1994
62824
0.000
Why?
WHITMAN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (542)
Explore
_
Co-Authors (129)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_